The University of Kansas Cancer Center-West is a clinical research site located in Kansas City, Kansas, United States 66112.
Crixeo Clinical Trials Trust Score: 82/100 (GOOD). This profile has not yet been claimed by the site owner.
The University of Kansas Cancer Center-West has participated in 2 clinical trials with 1 currently active.
Therapeutic areas: HER2-positive Breast Cancer, Adenocarcinoma of the Gastroesophageal Junction, Diffuse Gastric Adenocarcinoma.
Sponsors: Seagen, a wholly owned subsidiary of Pfizer, National Cancer Institute (NCI).
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Kansas · View every site in Kansas City
Trust Score: 82/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
The University of Kansas Cancer Center-West has a Crixeo Trust Score of 82/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
The University of Kansas Cancer Center-West has 2 clinical trials on record, with 1 currently active. Their work covers HER2-positive Breast Cancer, Adenocarcinoma of the Gastroesophageal Junction, Diffuse Gastric Adenocarcinoma.
The University of Kansas Cancer Center-West has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.